Longwood Founders Management raises $85m for its first fund with GlaxoSmithKline and Genzyme among its limited partners.
Drugs companies GlaxoSmithKline (GSK) and Genzyme have committed to the inaugural $85m healthcare fund raised by Longwood Founders Management.
Richard Aldrich, Michelle Dipp (pictured), and Christoph Westphal manage the fund. Dipp is also senior vice president of GSK’s Center of Excellence for External Drug Discovery, a role she took on after her then boss, Westphal, moved over in April last year to head the drugs company’s corporate venturing unit, SR One.
The two had joined GSK in 2007 when they…
